Market Cap 119.51M
Revenue (ttm) 49.22M
Net Income (ttm) -36.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -74.69%
Debt to Equity Ratio 0.58
Volume 125,588
Avg Vol 80,132
Day's Range N/A - N/A
Shares Out 55.58M
Stochastic %K 69%
Beta 2.91
Analysts Strong Sell
Price Target $5.60

Company Profile

Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is developing ALLO-501 to treat large B-cell lymphoma; ALLO-316, a gene-edited allogeneic CAR T-cell product targeting CD70; ALLO-819 to treat acute myeloid leukemia; ALLO-213 for the treatment of small...

Industry: Biotechnology
Sector: Healthcare
Phone: 33 1 81 69 16 00
Address:
8, rue de la Croix Jarry, Paris, France
trader_zone56
trader_zone56 Jul. 15 at 5:47 PM
0 · Reply
DarthGoat
DarthGoat Jul. 15 at 2:40 PM
$CLLS 👀also ...need $1.69
0 · Reply
Bulltrader988
Bulltrader988 Jul. 15 at 6:01 AM
$CLLS interesting move yesterday, Im expecting continuation today 👃👀 Stromg partnership with $AZN And buybacks approved... Hopefully they do a pr in near term 👃👀
0 · Reply
StockScanners
StockScanners Jul. 15 at 2:08 AM
$CLLS Keep watch if this holds above 1.83
0 · Reply
topstockalerts
topstockalerts Jul. 14 at 8:15 PM
Todays Top Gainers PT2 $DDC $BMGL $OP $CLLS $CAN
0 · Reply
_www_larval_com_
_www_larval_com_ Jul. 14 at 5:08 PM
$CLLS has reversed -5% lower to 27% (~501Kv) a moment ago, 07/18 options, follow for more volatility.
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Jul. 14 at 4:57 PM
$CLLS $2.30 huge cash $223M boom like $BMNR and $SONN
0 · Reply
redenergy
redenergy Jul. 14 at 4:57 PM
$CLLS clinical trials 🔗 https://trialradar.com/c/CLLS
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Jul. 14 at 4:52 PM
$CLLS $2.19 big cash $223M exploding like $BMGL and $SQFT
0 · Reply
PharmaExpert
PharmaExpert Jul. 14 at 3:45 PM
$AKBA, $SONN, $MCRB, $DARE, $CLLS 🔥🔥🔥🔥🔥
0 · Reply
Latest News on CLLS
Cellectis Reports Financial Results for the First Quarter 2025

May 12, 2025, 4:30 PM EDT - 2 months ago

Cellectis Reports Financial Results for the First Quarter 2025


Cellectis S.A. (CLLS) Q4 2024 Earnings Call Transcript

Mar 14, 2025, 10:36 AM EDT - 4 months ago

Cellectis S.A. (CLLS) Q4 2024 Earnings Call Transcript


Cellectis: Poised To Start Answering Questions In 2025

Dec 12, 2024, 3:08 PM EST - 7 months ago

Cellectis: Poised To Start Answering Questions In 2025


Cellectis S.A. (CLLS) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 1:59 PM EST - 9 months ago

Cellectis S.A. (CLLS) Q3 2024 Earnings Call Transcript


Cellectis: Cheap With Promising But Speculative Cancer Therapies

Aug 30, 2024, 10:25 AM EDT - 11 months ago

Cellectis: Cheap With Promising But Speculative Cancer Therapies


Cellectis S.A. (CLLS) Q1 2024 Earnings Call Transcript

May 30, 2024, 2:06 PM EDT - 1 year ago

Cellectis S.A. (CLLS) Q1 2024 Earnings Call Transcript


Cellectis Reports Financial Results for First Quarter 2024

May 28, 2024, 4:30 PM EDT - 1 year ago

Cellectis Reports Financial Results for First Quarter 2024


Cellectis SA (CLLS) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 2:22 PM EST - 1 year ago

Cellectis SA (CLLS) Q3 2023 Earnings Call Transcript


trader_zone56
trader_zone56 Jul. 15 at 5:47 PM
0 · Reply
DarthGoat
DarthGoat Jul. 15 at 2:40 PM
$CLLS 👀also ...need $1.69
0 · Reply
Bulltrader988
Bulltrader988 Jul. 15 at 6:01 AM
$CLLS interesting move yesterday, Im expecting continuation today 👃👀 Stromg partnership with $AZN And buybacks approved... Hopefully they do a pr in near term 👃👀
0 · Reply
StockScanners
StockScanners Jul. 15 at 2:08 AM
$CLLS Keep watch if this holds above 1.83
0 · Reply
topstockalerts
topstockalerts Jul. 14 at 8:15 PM
Todays Top Gainers PT2 $DDC $BMGL $OP $CLLS $CAN
0 · Reply
_www_larval_com_
_www_larval_com_ Jul. 14 at 5:08 PM
$CLLS has reversed -5% lower to 27% (~501Kv) a moment ago, 07/18 options, follow for more volatility.
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Jul. 14 at 4:57 PM
$CLLS $2.30 huge cash $223M boom like $BMNR and $SONN
0 · Reply
redenergy
redenergy Jul. 14 at 4:57 PM
$CLLS clinical trials 🔗 https://trialradar.com/c/CLLS
0 · Reply
CAPITALWHISPERER
CAPITALWHISPERER Jul. 14 at 4:52 PM
$CLLS $2.19 big cash $223M exploding like $BMGL and $SQFT
0 · Reply
PharmaExpert
PharmaExpert Jul. 14 at 3:45 PM
$AKBA, $SONN, $MCRB, $DARE, $CLLS 🔥🔥🔥🔥🔥
0 · Reply
mikefbi
mikefbi Jul. 7 at 8:25 PM
$CLLS Higher
0 · Reply
Bulltrader988
Bulltrader988 Jul. 5 at 7:06 AM
$CLLS 👀👀 https://www.stocktitan.net/news/CLLS/monthly-information-on-share-capital-and-company-voting-opx7ldtxygkf.html
0 · Reply
Bulltrader988
Bulltrader988 Jul. 3 at 7:27 PM
$CLLS still here 👃👀
0 · Reply
briefingcom
briefingcom Jul. 3 at 12:09 PM
Gapping Down: $INO -29.9% $FC -7% $CLLS -6.7%
0 · Reply
rlkloehn
rlkloehn Jul. 3 at 12:03 PM
$CLLS Registration on the F-3 shelf is periodic: it expires after 3 years and must be renewed if the company wants to continue to issue ADS through the ATM program. Therefore, the initial expiration date was July 6, 2025 (three years later). In order for the ATM program to remain legally operational after that date, Cellectis had to update or republish the document on July 7, 2025. In summary: this is not a new program, nor an additional fundraising - it is simply the formal update of the SEC file to maintain the ability to raise via ATM. Without this, Cellectis was blocked as early as July 6, which would have impacted its financing flexibility on Nasdaq.
0 · Reply
DonCorleone77
DonCorleone77 Jul. 2 at 8:23 PM
$CLLS Cellectis files $200M mixed securities shelf
0 · Reply
Bulltrader988
Bulltrader988 Jun. 30 at 6:34 PM
$CLLS interesting action today 👃👀
0 · Reply
mikefbi
mikefbi Jun. 30 at 5:17 PM
$CLLS Still
0 · Reply
Bulltrader988
Bulltrader988 Jun. 29 at 7:06 PM
$CLLS hopefully they will do a pr about the buybacks 👃👀
0 · Reply
Bulltrader988
Bulltrader988 Jun. 28 at 6:28 PM
$CLLS buybacks approved 👃👀 "...authorization to the Board of Directors to buy back shares of the Company" and "authorization to be granted to the Board of Directors to reduce the share capital by cancelling shares under the authorization for to buy back its own shares"... Both approved 👃👀 https://www.cellectis.com/uploads/files/VOTE_RESULT_2025.pdf
0 · Reply
bruceleeboy
bruceleeboy Jun. 28 at 1:06 AM
$IMNPQ.DL0922 Annual meetings for $MSCLF, $IVF ($NAYA) & $CLLS are all in. - Satellos got its RS approval and new bd member - Invo Fertility got its approval to increase common stock. (Still one proposal they need buy-in on. They will reconvene July 9th) - Cellectis got its approval to increase ordinary shares, do a share reduction via buyback and a new bd member Immune adjacent companies continue to position themselves for M&A, partnerships, etc.
0 · Reply
Bulltrader988
Bulltrader988 Jun. 26 at 8:39 PM
$CLLS 👀👀 https://www.stocktitan.net/news/CLLS/cellectis-reports-results-from-shareholders-meeting-held-on-june-26-bto7iggvnscz.html
0 · Reply